![Michael Seckler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Seckler
Företagsledare/Principal på
CORMEDIX INC.
Förmögenhet: 1 M $ per 2026-05-31
Profil
Michael D.
Seckler is currently Director at K2 Biotechnology Ventures LLC and Chief Commercial Officer & Executive VP at CorMedix, Inc. Former positions include Chief Executive Officer & Director at Evome Medical Technologies, Inc., Director at GLyPharma Therapeutic, Inc., Vice President-Global Marketing at Ferring Pharmaceuticals, Inc. from 2017 to 2019, and Chief Operating Officer at FerGene, Inc. from 2022 to 2023.
Education includes undergraduate and MBA degrees from The Pennsylvania State University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CORMEDIX INC. 0,17 % | 2026-01-08 | 133 156 ( 0,17 % ) | 1 M $ | 2026-05-31 |
Aktiva positioner av Michael Seckler
| Företag | Position | Start |
|---|---|---|
| CORMEDIX INC. | Företagsledare/Principal | 2026-01-08 |
K2 Biotechnology Ventures LLC
 K2 Biotechnology Ventures LLC Miscellaneous Commercial ServicesCommercial Services Engages in acceleration the commercialization of university, medical center and health care innovations | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Michael Seckler
| Företag | Position | Slut |
|---|---|---|
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer | Verksamhetschef | 2023-05-01 |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Företagsledare/Principal | - |
| EVOME MEDICAL TECHNOLOGIES INC. | Verkställande Direktör | - |
GLyPharma Therapeutic, Inc.
 GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology Develops oncology therapeutic treatment | Direktör/Styrelseledamot | - |
Michael Secklers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
6
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
CorMedix, Inc.
 CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Health Technology |
GLyPharma Therapeutic, Inc.
GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology Develops oncology therapeutic treatment | Health Technology |
Evome Medical Technologies, Inc.
 Evome Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes medical devices used for pain management and physical therapy treatments and isokinetic dynamometer | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer | Health Technology |
K2 Biotechnology Ventures LLC
K2 Biotechnology Ventures LLC Miscellaneous Commercial ServicesCommercial Services Engages in acceleration the commercialization of university, medical center and health care innovations | Commercial Services |
